{"text": "gilead sciences $gild getting positive press coverage, report finds URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER #stocks #traders &amp; #investors get the latest on $biib $amgn $gild and $celg bargain #biotechstocks in this great article b\u00a1\u00ad"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "AT_USER suntrust ... (rolls eyes) kinda missed a (the?) key $juno catalyst at ash... dose 2 clinical update\u00a1\u00ad URL"}
{"text": "rt AT_USER rt transplant_doc \"rt drkomanduri: breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in nejm. pr\u00a1\u00ad"}
{"text": "rt AT_USER the cart question: #ash17, are $gild's yescarta and $nvs's kymriah basically equivalent in dlbcl? if not, tell me the di\u00a1\u00ad"}
{"text": "rt transplant_doc \"rt drkomanduri: breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in n\u00a1\u00ad URL"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $biib $googl $fb"}
{"text": "rt AT_USER compare to $juno severe toxicities ($juno better efficacy/lower tox vs $gild/kite $nvs) ... $juno monday morning clinical\u00a1\u00ad"}
{"text": "interesting q&amp;a between AT_USER and $gild \u00a1\u00aa despite sadly not mentioning \"vein-to-vein\"\u00a1\u00ad URL"}
{"text": "rt AT_USER you'll be stunned by how many cancer immunotherapies are being developed AT_USER #stocks $bmy, $nvs, $gild URL"}
{"text": "ken griffin owns gilead sciences, inc. $gild. should you? stock has nice upside URL"}
{"text": "rt AT_USER the cart question: #ash17, are $gild's yescarta and $nvs's kymriah basically equivalent in dlbcl? if not, tell me the di\u00a1\u00ad"}
{"text": "you'll be stunned by how many cancer immunotherapies are being developed AT_USER #stocks $bmy, $nvs, $gild URL"}
{"text": "rt AT_USER mizuho #ash17 $gild/ $nvs: updated car-t data show durable effect given the further de-risking of the cart story / dur\u00a1\u00ad"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER $gild $ibb mizuho - gild should trade incrementally up on this car-t data tomorrow #ash17 URL"}
{"text": "rt AT_USER $gild , long vs 200d ma URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "AT_USER i think $gild is a winner as well"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "AT_USER AT_USER AT_USER exactly.  $juno dose level 2 early data drop showed much better safety &amp;\u00a1\u00ad URL"}
{"text": "rt AT_USER it\u00a1\u00afs here! axicabtagene in rel/ref b cell lymphoma. $kite $gild #tcellrx #ash17  URL"}
{"text": "rt AT_USER it\u00a1\u00afs here! axicabtagene in rel/ref b cell lymphoma. $kite $gild #tcellrx #ash17  URL"}
{"text": "rt AT_USER it\u00a1\u00afs here! axicabtagene in rel/ref b cell lymphoma. $kite $gild #tcellrx #ash17  URL"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "rt AT_USER breaking: neelapu et al axi-cel car-t rx for refractory #lymphoma published in AT_USER proud to be part of this landmark st\u00a1\u00ad"}
{"text": "data for $gild's fda-approved car t therapy show significant remission rates in 42% of non-hodgkin lymphoma patients URL"}
{"text": "rt AT_USER this is something i hadn't thought of: using medicare's outlier reimbursement mechanism to bill for car-t costs. from sam\u00a1\u00ad"}
{"text": "rt AT_USER monday just as big #ash17  $gild $wure $bmrn $once $kpti $blue $mgnx URL"}
{"text": "accuvest global advisors lowered its gilead sciences $gild holding URL"}
{"text": "$gild , long vs 200d ma URL"}
{"text": "rt AT_USER $gild zuma-1 lymphoma study update, via s neelapu #ash17 $nvs $juno URL"}
{"text": "rt AT_USER monday just as big #ash17  $gild $wure $bmrn $once $kpti $blue $mgnx URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $mu $googl $fb"}
{"text": "$gild kite announces long-term data from pivotal zuma-1 study of yescarta in patients with refractory large b-cell lymphoma at #ash2017"}
{"text": "monday just as big #ash17  $gild $wure $bmrn $once $kpti $blue $mgnx URL"}
{"text": "i\u00a1\u00afve written before that i\u00a1\u00afd jump in the moment $gild stops being (perceived as) a one trick pony. so this is it. t\u00a1\u00ad URL"}
{"text": "rt AT_USER mizhou #ash17 $gild $nvs updated car-t data show durable effect"}
{"text": "$amgn $gild $mrk $pfe $alioy $biib $bmy $incy $jnj $kite URL despite dropping its cap on m&amp;a sp\u00a1\u00ad URL"}
{"text": "rt AT_USER $gild zuma-1 lymphoma study update, via s neelapu #ash17 $nvs $juno URL"}
{"text": "$gild URL"}
{"text": "rt AT_USER $blue bb2121 bcma car update, via j kochenderfer #ash17 $juno $gild $nvs URL"}
{"text": "it\u00a1\u00afs here! axicabtagene in rel/ref b cell lymphoma. $kite $gild #tcellrx #ash17  URL"}
{"text": "AT_USER #ash17 car-t winners so far: 1/ $blue, $celg; 2/ $gild/$kite, $nvs;3/ $juno. the ultimate winner has to\u00a1\u00ad URL"}
{"text": "mizhou #ash17 $gild $nvs updated car-t data show durable effect"}
{"text": "rt AT_USER mizuho #ash17 $gild/ $nvs: updated car-t data show durable effect given the further de-risking of the cart story / dur\u00a1\u00ad"}
{"text": "rt AT_USER car t-cell therapies drive outcomes in lymphoma, myeloma URL $gild $kite $nvs #ash17"}
{"text": "rt AT_USER booth for $gild #cart #yescarta at #ash17 URL"}
{"text": "gilead sciences, inc. $gild is marco investment management llc\u00a1\u00afs 8th largest position URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER $gild $ibb mizuho - gild should trade incrementally up on this car-t data tomorrow #ash17 URL"}
{"text": "rt AT_USER $gild $kite announces long-term data from pivotal zuma-1 study of yescarta in patients with refractory large b-cell lymphoma\u00a1\u00ad"}
{"text": "AT_USER $gild coming out strong."}
{"text": "booth for $gild #cart #yescarta at #ash17 URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER car t-cell therapies drive outcomes in lymphoma, myeloma URL $gild $kite $nvs #ash17"}
{"text": "rt AT_USER $gild zuma-1 lymphoma study update, via s neelapu #ash17 $nvs $juno URL"}
{"text": "rt AT_USER car t-cell therapies drive outcomes in lymphoma, myeloma URL $gild $kite $nvs #ash17"}
{"text": "car t-cell therapies drive outcomes in lymphoma, myeloma URL $gild $kite $nvs #ash17"}
{"text": "$gild 's kite reveals long-term findings from study evaluating yescarta in refractory large b-cell lymphoma patients URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "rt AT_USER $gild $ibb mizuho - gild should trade incrementally up on this car-t data tomorrow #ash17 URL"}
{"text": "$gild $ibb mizuho - gild should trade incrementally up on this car-t data tomorrow #ash17 URL"}
{"text": "rt AT_USER mizuho #ash17 $gild/ $nvs: updated car-t data show durable effect given the further de-risking of the cart story / dur\u00a1\u00ad"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $amd $googl $fb"}
{"text": "rt AT_USER jcarh125, $juno anti-bcma car, to start clinical trials in q1 2018 #ash17 $blue $nvs $gild URL"}
{"text": "mizuho #ash17 $gild/ $nvs: updated car-t data show durable effect given the further de-risking of the cart story /\u00a1\u00ad URL"}
{"text": "rt AT_USER $gild URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER URL"}
{"text": "AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER AT_USER URL"}
{"text": "rt AT_USER $gild zuma-1 lymphoma study update, via s neelapu #ash17 $nvs $juno URL"}
{"text": "rt AT_USER AT_USER AT_USER only 8% $zuma-1 pts $kite $gild needing ivig is incredibly small compared to this AT_USER articl\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER AT_USER only 8% $zuma-1 pts $kite $gild needing ivig is incredibly small compared to this AT_USER articl\u00a1\u00ad"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "$gild URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "rt AT_USER undervalued company $gild URL"}
{"text": "rt AT_USER car-t therapies prove durable, stopping cancer for months \u00a1\u00aa even years \u00a1\u00aa in some patients URL the l\u00a1\u00ad"}
{"text": "bet inhibitors - biotech's next monster sector? URL includes $rvxcf $rvx.to $bmy $gild $gsk\u00a1\u00ad URL"}
